IMMIX BIOPHARMA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number
IMMIX BIOPHARMA, INC. (IMMX) had Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number of 5.30 million shares as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber · last filed 2026-08-07
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 5.30M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 5.52M shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 5.58M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 5.25M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number |
|---|---|
| 2026-06-30 | 5.30M shares 10-Q · filed 2026-08-07 |
| 2026-03-31 | 5.52M shares 10-Q · filed 2026-05-07 |
| 2025-12-31 | 5.58M shares 10-Q · filed 2026-08-07 |
| 2025-09-30 | 5.25M shares 10-Q · filed 2025-11-07 |
| 2025-06-30 | 2.31M shares 10-Q · filed 2025-08-08 |
| 2025-03-31 | 2.31M shares 10-Q · filed 2025-05-08 |
| 2024-12-31 | 2.31M shares 10-K/A · filed 2026-03-27 |
| 2024-09-30 | 2.31M shares 10-Q · filed 2024-11-12 |
| 2024-06-30 | 2.31M shares 10-Q · filed 2024-08-12 |
| 2024-03-31 | 2.31M shares 10-Q · filed 2024-05-09 |
| 2023-12-31 | 2.31M shares 10-K/A · filed 2026-03-27 |
| 2023-09-30 | 2.31M shares 10-Q · filed 2023-11-13 |
| 2023-06-30 | 397.50K shares 10-Q · filed 2023-08-11 |
| 2023-03-31 | 397.50K shares 10-Q · filed 2023-05-12 |
| 2022-12-31 | 397.50K shares 10-K · filed 2025-03-25 |
| 2022-09-30 | 397.50K shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 397.50K shares 10-Q · filed 2022-08-12 |
| 2022-03-31 | 397.50K shares 10-Q · filed 2022-05-13 |
| 2021-12-31 | 366.00K shares 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |